Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
live, attenuated, dengue serotype 1, 2, 3, 4 virus (1 trial)
tetravax-dv-tv003 (1 trial)
Dengue (Phase 2)
Trials (1 total)
Trial APIs (2 total)